• 1
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997. Hematology J 2000;1:5366.
  • 2
    Rödjer S, Swolin B, Roupe G. Mastocytosis—a myeloproliferative disorder? Proceedings ECCO-4, 4th European Conference on Clinical Oncology and Cancer Nursing, Spain, Madrid, 1–4 November, 1987, Abstract. p 171.
  • 3
    Swolin B, Rödjer S, Roupe G. Cytogenetic studies and in vitro colony growth in patients with mastocytosis. Blood 1987;70:19281932.
  • 4
    Bain B. Review: systemic mastocytosis and other mast cell neoplasms. Br J Haematol 1999;106:917.
  • 5
    Swolin B, Rödjer S, Roupe G. Cytogenetic studies in patients with mastocytosis. Cancer Genet Cytogenet 2000;120:131135.
  • 6
    Swolin B, Weinfeld A, Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 1988;72:386395.
  • 7
    Mertens F, Johansson B, Heim S, Kritoffersson U, Mitelman F. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia 1991;5:214220.
  • 8
    Lishner M, Confino-Cohen R, Mekori Y A, Feigin M, Manor Y, Goldberg A, Ravid M, Amiel A. Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J Allergy Clin Immunol 1996;98:199204.
  • 9
    ISCN. An International System for Human Cytogenetic Nomenclature. In: MitelmanF, editor. Basel: S. Karger; 1995.
  • 10
    Swolin B, Safai-Kutti S, Anghem E, Kutti J. No increased frequency of trisomies 8 and 9 by FISH method in untreated patients with essential thrombocythemia. Cancer Genet Cytogenet 2001;126:5659.